Get the Stockscreener App
56.97
1.01%
-0.43
State Street Spdr S P Pharmaceuticals Etf stock is traded at $56.97, with a volume of 98,097.
It is down -1.01% in the last 24 hours and up +2.18% over the past month.
See More
Previous Close:
$57.40
Open:
$57.43
24h Volume:
98,097
Relative Volume:
1.12
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.07%
1M Performance:
+2.18%
6M Performance:
+27.40%
1Y Performance:
+26.13%
1-Day Range:
$56.50
$57.59
1-Week Range:
$56.31
$57.85
52-Week Range:
$35.22
$58.00
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Name
State Street Spdr S P Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
56.83 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
337.59 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
684.77 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
687.79 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
273.29 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
603.66 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Latest News
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now? - MSN
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
Pharma stocks are close to ‘breaking out.’ Earnings could set them free. - MSN
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - sharewise.com
Pharma Stocks Are Close to Breaking Out. Earnings Could Set Them Free. - Barron's
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan - sharewise.com
XPH: Healthcare Dashboard For January (NYSEARCA:XPH) - Seeking Alpha
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
5 Biggest Clean Energy ETFs in 2026 - Investing News Network
Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report - FinancialContent
Should You Invest in the State Street SPDR S&P Semiconductor ETF (XSD)? - Yahoo Finance
ValuEngine Weekly Market Summary And Commentary - Seeking Alpha
01/12/2026 ValuEngine Weekly Market Summary & Commentary - The Globe and Mail
‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News. - Barron's
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
Better Small-Cap Growth ETF: Vanguard's VBK vs. State Street's SLYG - The Globe and Mail
Is Fidelity’s Health Care ETF A Good Buy Right Now? - AOL.com
Here's Why Biotech ETFs Are Rallying Hard - Yahoo Finance
Should You Invest in the State Street SPDR S&P Transportation ETF (XTN)? - Yahoo Finance
Stock Market Today: Dow, Nasdaq 100 And S&P 500 Futures Gain After December Jobs Data— General Motors, Tilray In Focus (UPDATED) - Benzinga
State Street SPDR S&P Pharmaceuticals ETF (NY: XPH - FinancialContent
5 ETFs to Buy for January - Yahoo Finance
Is State Street SPDR S&P Bank ETF (KBE) a Strong ETF Right Now? - Yahoo Finance
The Best S&P 500 ETF to Invest $5,000 in as 2026 Begins - The Motley Fool
As Artificial Intelligence Stocks Surge in Value, Health Care ETFs Take Center Stage for Growth - Bitget
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
Should You Invest in the State Street SPDR S&P Bank ETF (KBE)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Retail ETF (XRT)? - Yahoo Finance
Biotech and pharma stocks tumble as investors race into energy - MSN
Biotech and Pharma Stocks Tumble as Investors Race into Energy - Barron's
Should You Invest in the State Street SPDR S&P Insurance ETF (KIE)? - Yahoo Finance
This AI Infrastructure Stock Is 'Most Likely' To Be Added To S&P 500 In Q1 2026 According To Prediction Markets - Benzinga
Is State Street SPDR S&P Oil & Gas Exploration & Production ETF (XOP) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Homebuilders ETF (XHB) a strong ETF right now? - MSN
The Year-End 2025 Biotech Rally And What It Means For 2026 - Benzinga
Is State Street SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now? - Yahoo Finance
Stock Market Today: S&P 500, Dow Jones Futures Down As Santa Rally Hopes Fade—Investors Await Initial Jobless Claims ReportState Street SPDR S&P 500 ETF Trust (ARCA:SPY) - Benzinga
Chart of the Week: Moderna Stock May Be Finding a Bottom - Barron's
2026 S&P 500 Outlook: Look For Pharma Sector To Lead The Way With Potential Changes (SPY) - Seeking Alpha
4 Top-Ranked ETF Areas That Beat the Market in 2025 - Zacks Investment Research
SPDR Series TrustState Street SPDR S&P Pharmaceuticals ETF announces Quarterly dividend, payable on December 24, 2025 - MarketScreener
Is State Street SPDR S&P Software & Services ETF (XSW) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Homebuilders ETF (XHB)? - Nasdaq
Stock Market Today: Dow Jones, Nasdaq Futures Slip On Christmas Eve Despite Strong Q3 GDP Report— UiPath, AST SpaceMobile, Ramaco In Focus (UPDATED) - Benzinga
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for State Street Spdr S P Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):